Table of Contents Global Ovarian Cancer Drugs Market Research Report 2020, Forecast to 2025 1 Market Overview 1.1 Ovarian Cancer Drugs Definition 1.1.1 Analysis of Macroeconomic Indicators 1.1.2 Years Considered 1.2 Ovarian Cancer Drugs Segment by Type 1.2.1 Alkylating Agents 1.2.2 Mitotic Inhibitors 1.2.3 Antirheumatics 1.2.4 Antipsoriatics 1.2.5 VEGF/VEGFR Inhibitors 1.2.6 PARP Inhibitors 1.2.7 Antineoplastics 1.2.8 Others 1.3 Market Analysis by Application 1.3.1 Hospital Pharmacies 1.3.2 Drug Stores 1.3.3 Online Pharmacies 1.3.4 Others 1.4 Overview of Global Ovarian Cancer Drugs Market 1.4.1 Global Ovarian Cancer Drugs Revenue (2015-2025) 1.4.2 Global Ovarian Cancer Drugs Production and Capacity (2015-2025) 1.4.3 North America Ovarian Cancer Drugs Status and Prospect (2015-2025) 1.4.4 Europe Ovarian Cancer Drugs Status and Prospect (2015-2025) 1.4.5 Japan Ovarian Cancer Drugs Status and Prospect (2014-2025) 1.4.6 China Ovarian Cancer Drugs Status and Prospect (2015-2025) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 1.5.4 Porter's Five Forces Analysis 1.5.5 SWOT Analysis 1.6 Coronavirus Disease 2019 (Covid-19): Ovarian Cancer Drugs Industry Impact 1.6.1 How the Covid-19 is Affecting the Ovarian Cancer Drugs Industry 1.6.2 Ovarian Cancer Drugs Business Impact Assessment - Covid-19 1.6.3 Market Trends and Ovarian Cancer Drugs Potential Opportunities in the COVID-19 Landscape 1.6.4 Measures / Proposal against Covid-19 2 Global Ovarian Cancer Drugs Market Competition by Manufacturer 2.1 Global Ovarian Cancer Drugs Sales and Market Share by Manufacturer (2018-2020) 2.2 Global Ovarian Cancer Drugs Revenue and Market Share by Manufacturer (2018-2020) 2.3 Global Ovarian Cancer Drugs Industry Concentration Ratio (CR5 and HHI) 2.4 Top 5 Ovarian Cancer Drugs Manufacturer Market Share 2.5 Top 10 Ovarian Cancer Drugs Manufacturer Market Share 2.6 Date of Key Manufacturers Enter into Ovarian Cancer Drugs Market 2.7 Key Manufacturers Ovarian Cancer Drugs Product Offered 2.8 Mergers & Acquisitions Planning 3 Analysis of Ovarian Cancer Drugs Industry Key Manufacturers 3.1 Allergan plc 3.1.1 Company Details 3.1.2 Product Information 3.1.3 Allergan plc Ovarian Cancer Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.1.4 Main Business Overview 3.1.5 Allergan plc News 3.2 Pfizer, Inc. 3.2.1 Company Details 3.2.2 Product Information 3.2.3 Pfizer, Inc. Ovarian Cancer Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.2.4 Main Business Overview 3.2.5 Pfizer, Inc. News 3.3 Merck KGaA 3.3.1 Company Details 3.3.2 Product Information 3.3.3 Merck KGaA Ovarian Cancer Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.3.4 Main Business Overview 3.3.5 Merck KGaA News 3.4 AstraZeneca 3.4.1 Company Details 3.4.2 Product Information 3.4.3 AstraZeneca Ovarian Cancer Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.4.4 Main Business Overview 3.4.5 AstraZeneca News 3.5 F. Hoffmann-La Roche AG 3.5.1 Company Details 3.5.2 Product Information 3.5.3 F. Hoffmann-La Roche AG Ovarian Cancer Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.5.4 Main Business Overview 3.5.5 F. Hoffmann-La Roche AG News 3.6 Johnson & Johnson 3.6.1 Company Details 3.6.2 Product Information 3.6.3 Johnson & Johnson Ovarian Cancer Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.6.4 Main Business Overview 3.6.5 Johnson & Johnson News 3.7 Syndax Pharmaceuticals, Inc. 3.7.1 Company Details 3.7.2 Product Information 3.7.3 Syndax Pharmaceuticals, Inc. Ovarian Cancer Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.7.4 Main Business Overview 3.7.5 Syndax Pharmaceuticals, Inc. News 3.8 Clovis Oncology 3.8.1 Company Details 3.8.2 Product Information 3.8.3 Clovis Oncology Ovarian Cancer Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.8.4 Main Business Overview 3.8.5 Clovis Oncology News 4 Global Ovarian Cancer Drugs Market Size Categorized by Regions (2015-2020) 4.1 Global Ovarian Cancer Drugs Sales Market Share by Region 4.2 Global Ovarian Cancer Drugs Revenue Market Share by Region (2015-2019) 4.3 Global Ovarian Cancer Drugs Sales, Revenue, Price and Gross Margin (2015-2020) 4.4 North America Ovarian Cancer Drugs Market Size Detail 4.4.1 North America Ovarian Cancer Drugs Sales Growth Rate (2015-2020) 4.4.2 North America Ovarian Cancer Drugs Sales, Revenue, Price and Gross Margin (2015-2020) 4.5 Europe Ovarian Cancer Drugs Market Size Detail 4.5.1 Europe Ovarian Cancer Drugs Sales Growth Rate (2015-2020) 4.5.2 Europe Ovarian Cancer Drugs Sales, Revenue, Price and Gross Margin (2015-2020) 4.6 Japan Ovarian Cancer Drugs Market Size Detail 4.6.1 Japan Ovarian Cancer Drugs Sales Growth Rate (2015-2020) 4.6.2 Japan Ovarian Cancer Drugs Sales, Revenue, Price and Gross Margin (2015-2020) 4.7 China Ovarian Cancer Drugs Market Size Detail 4.7.1 China Ovarian Cancer Drugs Sales Growth Rate (2015-2020) 4.7.2 China Ovarian Cancer Drugs Sales, Revenue, Price and Gross Margin (2015-2020) 5 Global Ovarian Cancer Drugs Market Segment by Type 5.1 Global Ovarian Cancer Drugs Revenue, Sales and Market Share by Type (2015-2020) 5.1.1 Global Ovarian Cancer Drugs Sales and Market Share by Type (2015-2020) 5.1.2 Global Ovarian Cancer Drugs Revenue and Market Share by Type (2015-2020) 5.2 Alkylating Agents Sales Growth Rate and Price 5.2.1 Global Alkylating Agents Sales Growth Rate (2015-2020) 5.2.2 Global Alkylating Agents Price (2015-2020) 5.3 Mitotic Inhibitors Sales Growth Rate and Price 5.3.1 Global Mitotic Inhibitors Sales Growth Rate (2015-2020) 5.3.2 Global Mitotic Inhibitors Price (2015-2020) 5.4 Antirheumatics Sales Growth Rate and Price 5.4.1 Global Antirheumatics Sales Growth Rate (2015-2020) 5.4.2 Global Antirheumatics Price (2015-2020) 5.5 Antipsoriatics Sales Growth Rate and Price 5.5.1 Global Antipsoriatics Sales Growth Rate (2015-2020) 5.5.2 Global Antipsoriatics Price (2015-2020) 5.6 VEGF/VEGFR Inhibitors Sales Growth Rate and Price 5.6.1 Global VEGF/VEGFR Inhibitors Sales Growth Rate (2015-2020) 5.6.2 Global VEGF/VEGFR Inhibitors Price (2015-2020) 5.7 PARP Inhibitors Sales Growth Rate and Price 5.7.1 Global PARP Inhibitors Sales Growth Rate (2015-2020) 5.7.2 Global PARP Inhibitors Price (2015-2020) 5.8 Antineoplastics Sales Growth Rate and Price 5.8.1 Global Antineoplastics Sales Growth Rate (2015-2020) 5.8.2 Global Antineoplastics Price (2015-2020) 5.9 Others Sales Growth Rate and Price 5.9.1 Global Others Sales Growth Rate (2015-2020) 5.9.2 Global Others Price (2015-2020) 6 Global Ovarian Cancer Drugs Market Segment by Application 6.1 Global Ovarian Cancer Drugs Sales Market Share by Application (2015-2020) 6.2 Hospital Pharmacies Sales Growth Rate (2015-2020) 6.3 Drug Stores Sales Growth Rate (2015-2020) 6.4 Online Pharmacies Sales Growth Rate (2015-2020) 6.5 Others Sales Growth Rate (2015-2020) 7 Ovarian Cancer Drugs Related Market Analysis 7.1 Upstream Analysis 7.1.1 Macro Analysis of Upstream Markets 7.1.2 Key Players in Upstream Markets 7.1.3 Upstream Market Trend Analysis 7.1.4 Ovarian Cancer Drugs Manufacturing Cost Analysis 7.2 Downstream Market Analysis 7.2.1 Macro Analysis of Down Markets 7.2.2 Key Players in Down Markets 7.2.3 Downstream Market Trend Analysis 7.2.4 Sales Channel, Distributors, Traders and Dealers 8 Global Ovarian Cancer Drugs Market Forecast 8.1 Global Ovarian Cancer Drugs Sales, Revenue Forecast 8.1.1 Global Ovarian Cancer Drugs Sales Growth Rate Forecast (2020-2025) 8.1.2 Global Ovarian Cancer Drugs Revenue and Growth Rate Forecast (2020-2025) 8.1.3 Global Ovarian Cancer Drugs Price and Trend Forecast (2020-2025) 8.2 Global Ovarian Cancer Drugs Sales Forecast by Region (2020-2025) 8.2.1 North America Ovarian Cancer Drugs Sales, Revenue Forecast (2020-2025) 8.2.2 Europe Ovarian Cancer Drugs Sales, Revenue Forecast (2020-2025) 8.2.3 Japan Ovarian Cancer Drugs Production, Revenue Forecast (2020-2025) 8.2.4 China Ovarian Cancer Drugs Production, Revenue Forecast (2020-2025) 9 Research Findings and Conclusion 10 Appendix

List of Tables and Figures Figure Ovarian Cancer Drugs Picture Table Global Ovarian Cancer Drugs Sales by Type Figure Global Sales Market Share of Ovarian Cancer Drugs by Product Type in 2019 Table Breakdown of Ovarian Cancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) Figure Ovarian Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure Alkylating Agents Picture Figure Mitotic Inhibitors Picture Figure Antirheumatics Picture Figure Antipsoriatics Picture Figure VEGF/VEGFR Inhibitors Picture Figure PARP Inhibitors Picture Figure Antineoplastics Picture Figure Others Picture Table Global Ovarian Cancer Drugs Sales by Application Figure Global Ovarian Cancer Drugs Sales Market Share by Application in 2019 Figure Hospital Pharmacies Picture Figure Drug Stores Picture Figure Online Pharmacies Picture Figure Others Picture Table Ovarian Cancer Drugs Market Size Comparison by Region (2019-2025) (K Units) & (Million US$) Figure Global Ovarian Cancer Drugs Revenue (Million US$) (2015-2025) Figure Global Ovarian Cancer Drugs Production (K Units) (2015-2025) Figure North America Ovarian Cancer Drugs Revenue (Million US$) Growth Rate (2015-2025) Figure Europe Ovarian Cancer Drugs Revenue (Million US$) Growth Rate (2015-2025) Figure Japan Ovarian Cancer Drugs Revenue (Million US$) Growth Rate (2014-2025) Figure China Ovarian Cancer Drugs Revenue (Million US$) Growth Rate (2015-2025) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table SWOT Analysis Table Global Ovarian Cancer Drugs Sales by Manufacturer (2018-2020) Figure Global Ovarian Cancer Drugs Sales Market Share by Manufacturer in 2019 Table Global Ovarian Cancer Drugs Revenue by Manufacturer (2018-2020) Figure Global Ovarian Cancer Drugs Revenue Market Share by Manufacturer in 2019 Table Global Ovarian Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 Ovarian Cancer Drugs Manufacturer (Revenue) Market Share in 2019 Figure Top 10 Ovarian Cancer Drugs Manufacturer (Revenue) Market Share in 2019 Table Date of Key Manufacturers Enter into Ovarian Cancer Drugs Market Table Key Manufacturers Ovarian Cancer Drugs Product Type Table Mergers & Acquisitions Planning Table Allergan plc Company Profile Figure Ovarian Cancer Drugs Product Picture and Specifications of Allergan plc Table Ovarian Cancer Drugs Production, Price, Revenue and Gross Margin of 2018-2020 Figure Allergan plc Ovarian Cancer Drugs Market Share (2018-2020) Table Allergan plc Main Business Table Allergan plc Recent Development Table Pfizer, Inc. Company Profile Figure Ovarian Cancer Drugs Product Picture and Specifications of Pfizer, Inc. Table Ovarian Cancer Drugs Production, Price, Revenue and Gross Margin of 2018-2020 Figure Pfizer, Inc. Ovarian Cancer Drugs Market Share (2018-2020) Table Pfizer, Inc. Main Business Table Pfizer, Inc. Recent Development Table Merck KGaA Company Profile Figure Ovarian Cancer Drugs Product Picture and Specifications of Merck KGaA Table Ovarian Cancer Drugs Production, Price, Revenue and Gross Margin of 2018-2020 Figure Merck KGaA Ovarian Cancer Drugs Market Share (2018-2020) Table Merck KGaA Main Business Table Merck KGaA Recent Development Table AstraZeneca Company Profile Figure Ovarian Cancer Drugs Product Picture and Specifications of AstraZeneca Table Ovarian Cancer Drugs Production, Price, Revenue and Gross Margin of 2018-2020 Figure AstraZeneca Ovarian Cancer Drugs Market Share (2018-2020) Table AstraZeneca Main Business Table AstraZeneca Recent Development Table F. Hoffmann-La Roche AG Company Profile Figure Ovarian Cancer Drugs Product Picture and Specifications of F. Hoffmann-La Roche AG Table Ovarian Cancer Drugs Production, Price, Revenue and Gross Margin of 2018-2020 Figure F. Hoffmann-La Roche AG Ovarian Cancer Drugs Market Share (2018-2020) Table F. Hoffmann-La Roche AG Main Business Table F. Hoffmann-La Roche AG Recent Development Table Johnson & Johnson Company Profile Figure Ovarian Cancer Drugs Product Picture and Specifications of Johnson & Johnson Table Ovarian Cancer Drugs Production, Price, Revenue and Gross Margin of 2018-2020 Figure Johnson & Johnson Ovarian Cancer Drugs Market Share (2018-2020) Table Johnson & Johnson Main Business Table Johnson & Johnson Recent Development Table Syndax Pharmaceuticals, Inc. Company Profile Figure Ovarian Cancer Drugs Product Picture and Specifications of Syndax Pharmaceuticals, Inc. Table Ovarian Cancer Drugs Production, Price, Revenue and Gross Margin of 2018-2020 Figure Syndax Pharmaceuticals, Inc. Ovarian Cancer Drugs Market Share (2018-2020) Table Syndax Pharmaceuticals, Inc. Main Business Table Syndax Pharmaceuticals, Inc. Recent Development Table Clovis Oncology Company Profile Figure Ovarian Cancer Drugs Product Picture and Specifications of Clovis Oncology Table Ovarian Cancer Drugs Production, Price, Revenue and Gross Margin of 2018-2020 Figure Clovis Oncology Ovarian Cancer Drugs Market Share (2018-2020) Table Clovis Oncology Main Business Table Clovis Oncology Recent Development Table Global Ovarian Cancer Drugs Sales (K Units) by Region (2015-2020) Table Global Ovarian Cancer Drugs Sales Market Share by Region (2015-2019) Figure Global Ovarian Cancer Drugs Sales Market Share by Region (2015-2019) Figure Global Ovarian Cancer Drugs Sales Market Share by Region in 2018 Table Global Ovarian Cancer Drugs Revenue (Million US$) by Region (2015-2020) Table Global Ovarian Cancer Drugs Revenue Market Share by Region (2015-2020) Figure Global Ovarian Cancer Drugs Revenue Market Share by Region (2015-2020) Figure Global Ovarian Cancer Drugs Revenue Market Share by Region in 2019 Table Global Ovarian Cancer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure North America Ovarian Cancer Drugs Sales (K Units) Growth Rate (2015-2020) Figure Europe Ovarian Cancer Drugs Sales (K Units) Growth Rate (2015-2020) Table Europe Ovarian Cancer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure Japan Ovarian Cancer Drugs Sales (K Units) Growth Rate (2015-2020) Table Japan Ovarian Cancer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure China Ovarian Cancer Drugs Sales (K Units) Growth Rate (2015-2020) Table China Ovarian Cancer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table Global Ovarian Cancer Drugs Sales by Type (2015-2020) Table Global Ovarian Cancer Drugs Sales Market Share by Type (2015-2020) Figure Global Ovarian Cancer Drugs Sales Market Share by Type in 2019 Table Global Ovarian Cancer Drugs Revenue by Type (2015-2020) Table Global Ovarian Cancer Drugs Revenue Market Share by Type (2015-2020) Figure Global Ovarian Cancer Drugs Revenue Market Share by Type in 2019 Figure Global Alkylating Agents Sales Growth Rate (2015-2025) Figure Global Alkylating Agents Price (2015-2020) Figure Global Mitotic Inhibitors Sales Growth Rate (2015-2025) Figure Global Mitotic Inhibitors Price (2015-2020) Figure Global Antirheumatics Sales Growth Rate (2015-2025) Figure Global Antirheumatics Price (2015-2020) Figure Global Antipsoriatics Sales Growth Rate (2015-2025) Figure Global Antipsoriatics Price (2015-2020) Figure Global VEGF/VEGFR Inhibitors Sales Growth Rate (2015-2025) Figure Global VEGF/VEGFR Inhibitors Price (2015-2020) Figure Global PARP Inhibitors Sales Growth Rate (2015-2025) Figure Global PARP Inhibitors Price (2015-2020) Figure Global Antineoplastics Sales Growth Rate (2015-2025) Figure Global Antineoplastics Price (2015-2020) Figure Global Others Sales Growth Rate (2015-2025) Figure Global Others Price (2015-2020) Table Global Ovarian Cancer Drugs Sales Market Share by Application (2015-2020) Figure Global Ovarian Cancer Drugs Sales Market Share by Application in 2019 Figure Global Hospital Pharmacies Sales Growth Rate (2015-2025) Figure Global Drug Stores Sales Growth Rate (2015-2025) Figure Global Online Pharmacies Sales Growth Rate (2015-2025) Figure Global Others Sales Growth Rate (2015-2025) Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Ovarian Cancer Drugs Table Key Players of Downstream Markets Figure Sales Channel Figure Global Ovarian Cancer Drugs Production (K Units) Growth Rate Forecast (2020-2025) Figure Global Ovarian Cancer Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Global Ovarian Cancer Drugs Price and Trend Forecast (2020-2025) Table Global Ovarian Cancer Drugs Sales (K Units) Forecast by Region (2020-2025) Figure Global Ovarian Cancer Drugs Production Market Share Forecast by Region (2020-2025) Figure North America Ovarian Cancer Drugs Sales (K Units) Growth Rate Forecast (2020-2025) Figure North America Ovarian Cancer Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Europe Ovarian Cancer Drugs Sales (K Units) Growth Rate Forecast (2020-2025) Figure Europe Ovarian Cancer Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Japan Ovarian Cancer Drugs Production (K Units) Growth Rate Forecast (2020-2025) Figure Japan Ovarian Cancer Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure China Ovarian Cancer Drugs Production (K Units) Growth Rate Forecast (2020-2025) Figure China Ovarian Cancer Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Methodology/Research Approach Figure Market Size Estimation Figure Author List

Allergan plc Pfizer, Inc. Merck KGaA AstraZeneca F. Hoffmann-La Roche AG Johnson & Johnson